Pharma channel feed

J&J and Bay­er to lay off al­most 300 staffers in New Jer­sey

7 months ago
People

23andMe CEO says she is no longer open to out­side takeover of­fers

7 months ago
Financing
Deals

Fed­er­al judge dis­miss­es long­stand­ing suit over Bris­tol My­er­s' $74B Cel­gene buy­out

7 months ago
Law

Cal­i­for­ni­a's Gavin New­som ve­toes bi­par­ti­san PBM re­form bill

7 months ago

J&J pulls the plug on 340B re­bate mod­el changes op­posed by gov­ern­ment

7 months ago
FDA+
Law

Up­dat­ed: Pfiz­er to fur­ther de­crease stake in con­sumer health com­pa­ny Ha­le­on

7 months ago

Lil­ly-part­nered ra­dio­phar­ma start­up Ak­tis On­col­o­gy rais­es $175M

7 months ago
Financing
Startups

For some mul­ti­ple myelo­ma pa­tients, Carvyk­ti cut risk of death by 45%

7 months ago
R&D
Cell/Gene Tx

US gov­ern­ment re­news threats over J&J's pro­posed 340B re­bate mod­el

7 months ago
FDA+
Law

No­vo Nordisk to de­crease some in­sulin pen man­u­fac­tur­ing, tran­si­tion sup­ply

7 months ago
Manufacturing

FDA ap­proves Dupix­ent in COPD, open­ing ‘next chap­ter’ for Sanofi and Re­gen­eron’s best­seller

7 months ago
FDA+

Cas­sa­va and its for­mer ex­ecs set­tle SEC charges for ‘mis­lead­ing’ Alzheimer’s drug da­ta

7 months ago
Law

FDA ap­proves Bris­tol My­ers and Karuna's schiz­o­phre­nia drug, in mile­stone for psy­chi­a­try

7 months ago
FDA+

FDA lifts hold on Bio­mea’s di­a­betes tri­als

7 months ago
FDA+

As­traZeneca's lung can­cer block­buster Tagris­so wins la­bel ex­pan­sion in ear­ly-stage EGFR pa­tients

7 months ago
FDA+

Genen­tech's Gazy­va hits pri­ma­ry end­point in late-stage kid­ney dis­ease tri­al

7 months ago
R&D

Up­dat­ed: FDA ad­comm votes to lim­it Op­di­vo, Keytru­da use in stom­ach, esophageal can­cers based on key bio­mark­er

7 months ago
FDA+

Pfiz­er pulls sick­le cell drug from all mar­kets af­ter da­ta re­view showed rise in deaths and com­pli­ca­tions

7 months ago
FDA+

UK watch­dog crit­i­cizes Mod­er­na for Covid-19 tri­al's use of What­sApp to dan­gle pay­ments to chil­dren

7 months ago
Marketing

EMA to dis­cuss Pfiz­er's sick­le cell drug Oxbry­ta af­ter pa­tient deaths

7 months ago
FDA+

Bal­ti­more sues Bio­gen, say­ing the com­pa­ny col­lud­ed with PBMs to min­i­mize gener­ic com­pe­ti­tion

7 months ago
Law

Emer­gent says it has $400M in or­ders re­lat­ed to mpox out­break 

7 months ago
Manufacturing

FDA OKs In­tra­Bio's drug less than a week af­ter rare dis­ease's first-ever ap­proval

7 months ago
FDA+

2sev­en­ty bio, Bris­tol My­ers stop late-stage Abec­ma study in mul­ti­ple myelo­ma due to re­cruit­ment chal­lenges

7 months ago
R&D
First page Previous page 31323334353637 Next page Last page
A service from the Financial Times